Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01E schedule optimization study in African children
2016-000290-20Phase 2
- Sponsor
- GSK
- Start
- Sep 2017
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of RTS,S in malaria (3 arms), sponsored by GSK. Primary endpoints: Primary efficacy endpoint and Primary objective comparison.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on 2016-000290-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000290-20.